Metacrine, Inc.
MTCR · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.01 | -0.61 | 0.00 |
| FCF Yield | -166.15% | -49.27% | -12.31% | -11.67% |
| EV / EBITDA | 0.56 | 0.35 | -7.99 | -8.45 |
| Quality | ||||
| ROIC | -82.30% | -35.44% | -54.25% | -36.34% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.76 | 0.97 | 0.96 | 0.99 |
| Growth | ||||
| Revenue 3-Year CAGR | – | -100.00% | -100.00% | 1,131,751.20% |
| Free Cash Flow Growth | -29.52% | -30.85% | -6.35% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 1.02 | 2.37 | 0.15 | 0.52 |
| Interest Coverage | -50.81 | -36.25 | -86.47 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |